QNCX
Quince Therapeutics·NASDAQ
--
--(--)
--
--(--)
QNCX Filings
Filing Date
Form Description
Form Type
2026-03-30
Form 8-K - Current report
Key Events
2026-03-30 · Key Events
Form 8-K - Current report
2026-03-20
Form 8-K - Current report
Key Events
2026-03-20 · Key Events
Form 8-K - Current report
2026-03-05
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-03-05 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-12
Form 8-K - Current report
Key Events
2026-02-12 · Key Events
Form 8-K - Current report
2026-02-02
Form 8-K - Current report
Key Events
2026-02-02 · Key Events
Form 8-K - Current report
2026-01-29
Form 8-K - Current report
Key Events
2026-01-29 · Key Events
Form 8-K - Current report
2026-01-23
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-23 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-23
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-23 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-23
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-23 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-21
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-21 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
